AGE (AGE) Stock Price, News & Analysis

Name: AGE (AGE) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

AGE NYSE

Company Description

AGE (NYSE: AGE) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for AGE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

March 22, 2024

-3.30%

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

earnings

November 14, 2023

-5.63%

AgeX Therapeutics Reports Third Quarter 2023 Financial Results

earnings

August 30, 2023

-0.15%

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

acquisition

August 14, 2023

-9.65%

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

earnings

July 24, 2023

-2.90%

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

July 21, 2023

+1.03%

AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock

AGE has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 9 with negative movement. Key topics include earnings, acquisition. View all AGE news →

SEC Filings

View All

No SEC filings available for AGE.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

AGE Company Profile & Sector Positioning

AGE (AGE) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NYSE.